1049665-17-9

Basic information

• Product Name: (S)-2-[4-bromo-2-((3S,5R)-3,5-dimethyl-piperidine-1-carbonyl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
• Synonyms: (S)-2-[4-bromo-2-((3S,5R)-3,5-dimethyl-piperidine-1-carbonyl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
• CAS NO: 1049665-17-9
• Molecular Weight: 508.456
• Mol File: 1049665-17-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-2-[4-bromo-2-((3S,5R)-3,5-dimethyl-piperidine-1-carbonyl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-[4-bromo-2-((3S,5R)-3,5-dimethyl-piperidine-1-carbonyl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(1049665-17-9)
• EPA Substance Registry System: (S)-2-[4-bromo-2-((3S,5R)-3,5-dimethyl-piperidine-1-carbonyl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(1049665-17-9)

Safety Data

• Hazardous Substances Data: 1049665-17-9(Hazardous Substances Data)

Upstream product

• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 1034257-10-7 (2-amino-5-bromophenyl)((3R,5S)-3,5-dimethylpiperidin-1-yl)methanone 

Relevant articles and documents

Hepatitis C virus polymerase inhibitors

The invention provides a compound of formula: and methods for making and using the same, where R1 and R2 are independently hydrogen, C1-6 alkyl or C1-6 haloalkyl; R3 is hydrogen, halogen, C1-6 alkyl or C1-6 alkoxy; R4 is hydrogen or halogen; and R5 is a mono- or di-amino acid moiety, a succinic acid moiety, a urea moiety, or a derivative thereof. The invention also provides pharmaceutical compositions comprising a compound of formula I, and methods for making and using the same.